Myriad Pharmaceuticals
Myriad Pharmaceuticals: annual report for the year ended Jun 30, 2009
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001193125-09-199114
- Document
- 10-K
- Exhibit 10.10
- Form of employment agreement
- Exhibit 10.11
- Offer letter - robert j. lollini
- Exhibit 10.12
- Management performance-incentive bonus program
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float not reported.
